PDL Biopharma
PDLI
#8082
Rank
โ‚ฌ0.23 B
Marketcap
2,09ย โ‚ฌ
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Market capitalization of PDL Biopharma (PDLI)

Last known market cap: โ‚ฌ0.23 Billion

As of February 2026 PDL Biopharma has a market cap of โ‚ฌ0.23 Billion. This makes PDL Biopharma the world's 8082th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PDL Biopharma from 2001 to 2021

End of year Market Cap

Year Marketcap Change
2021โ‚ฌ0.24 B8.61%
2020โ‚ฌ0.22 B-36.3%
2019โ‚ฌ0.36 B4.05%
2018โ‚ฌ0.34 B-1.81%
2017โ‚ฌ0.35 B5.64%
2016โ‚ฌ0.33 B-37.27%
2015โ‚ฌ0.53 B-48.27%
2014โ‚ฌ1.02 B20.22%
2013โ‚ฌ0.85 B14.93%
2012โ‚ฌ0.74 B11.46%
2011โ‚ฌ0.66 B2.07%
2010โ‚ฌ0.65 B14.28%
2009โ‚ฌ0.57 B8.33%
2008โ‚ฌ0.52 B-62.55%
2007โ‚ฌ1.41 B-19.63%
2006โ‚ฌ1.75 B-34.71%
2005โ‚ฌ2.68 B84.15%
2004โ‚ฌ1.45 B9.37%
2003โ‚ฌ1.33 B84.08%
2002โ‚ฌ0.72 B-78.03%
2001โ‚ฌ3.29 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Eli Lilly
LLY
โ‚ฌ786.63 B 329,501.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ170.99 B 71,546.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ0.11 B-51.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚ฌ0.12 B-46.12%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
โ‚ฌ0.60 B 154.72%๐Ÿ‡บ๐Ÿ‡ธ USA